SelectScience
Join Free
NewsClinical Diagnostics

Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026

Roche

Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics

28 Jul 2026

Roche will showcase intelligent laboratory solutions and high-precision diagnostic instruments at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Scientific Meeting & Clinical Lab Expo, taking place in Anaheim, California.

At booth no. 2901, the company will present integrated diagnostic systems designed to help clinical laboratories address workforce shortages, streamline complex workflows, expand access to high-precision testing and improve operational efficiency across core, molecular and pathology labs, as well as point-of-care settings.

Supporting ADLM’s focus on workforce and workflow challenges

Roche’s presence at ADLM 2026 aligns with the meeting’s emphasis on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges. Visitors will be able to explore interactive demonstrations focused on neurology, oncology and cardiometabolic health, highlighting how Roche’s portfolio supports clinical decision-making across diverse care pathways.

Roche will feature the new AXELIOS 1 next-generation sequencing platform* and, for the first time, a live, in-booth unveiling of the cobas® Mass Spec solution on Tuesday, July 28 at 10:15 PDT. Attendees will gain an exclusive look at Roche’s approach to automated clinical mass spectrometry and integrated diagnostics.

Expanding access to high-precision science through mass spectrometry automation

The cobas® Mass Spec solution, which includes the cobas® i 601 analyzer and Ionify® reagents with CLIA ‘moderate complexity’ classification, is designed to bring highly complex testing out of specialized units and into routine clinical core laboratories.

From sample preparation to final result interpretation, the solution integrates end-to-end processing and eliminates labor-intensive manual workflows, helping laboratory professionals focus on higher-value tasks while maintaining analytical quality.

Featured automation and analytical units in the Core Lab space include:

  • cobas® connection modules (CCM) Vertical
  • cobas® pro integrated solutions
  • cobas® pure integrated solution
  • cobas® mobile solution

Redefining genomic discovery with next-generation sequencing by expansion

The AXELIOS 1 next-generation sequencing (NGS) platform*, powered by sequencing by expansion (SBX) technology, is designed to make genomics research faster, more flexible and more affordable for laboratories of all sizes. By reducing sequencing time from days to hours, AXELIOS 1 is designed to accelerate genomic discovery and support a broad range of research applications.

Additional molecular platforms featured at the booth include:

  • cobas® 6800/8800 system (Version 2.0)
  • cobas® 5800 system
  • cobas® eplex system
  • cobas® prime pre-analytical system

AI and automation to address pathology labor shortages

Through expanded information solutions and deep software integrations, Roche is demonstrating how intelligent automation, cloud-based workflow visibility and AI-enabled diagnostics can reduce manual touchpoints and help alleviate pathology labor shortages. Roche’s staining and digital pathology solutions are designed to create a unified workflow that streamlines diagnostics from slide preparation to image review.

Featured systems include:

  • VENTANA® DP 600 slide scanner
  • BenchMark ULTRA PLUS system

Expanding access to point-of-care diagnostic solutions

Roche is also highlighting decentralized testing through a robust point-of-care ecosystem designed to facilitate rapid triage and improve operational efficiency in clinical settings. Featured point-of-care systems include:

  • cobas® liat system
  • cobas® pulse system**
  • cobas® Urisys® 1100
  • CoaguChek® XS Plus system

Neurology and Alzheimer’s disease diagnostics

Building on recent U.S. Food and Drug Administration (FDA) clearances, Roche is spotlighting its Elecsys® Phospho-Tau (181P) blood-based biomarker test that aids in ruling out Alzheimer’s disease–associated amyloid pathology in adult patients aged 55 and older who present with signs and symptoms of cognitive decline.

navify Digital Solutions: Turning lab and clinical data into actionable insights

Centralized interactive stations across the booth will showcase the navify® Digital Solutions portfolio, including navify Lab Operations, navify Analytics, navify Quality Suite and navify POC Operations. These systems are designed to turn complex laboratory data into actionable insights by providing proactive issue detection, workload prediction and comprehensive operational visibility across core lab and point-of-care environments.

Visitors will also get an exclusive look at upcoming enterprise digital solutions, including navify Inventory Solutions and navify Algo Suite. Navify Algo Suite is a cloud-based platform that integrates clinical algorithms from Roche and its partners into existing Electronic Medical Records (EMRs) to enhance hospital workflows and support data-driven clinical decisions.

* The AXELIOS 1 Sequencing Platform is available for Research Use Only. Not for use in diagnostic procedures.

** The cobas pulse system is not for use with capillary fingerstick samples and is not for sale in the US.

Follow SelectScience throughout ADLM 2026 for exclusive interviews, daily round-up articles, Scientists' Choice Awards® coverage, and the latest news from the exhibition floor.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Frequently asked questions

What solutions will Roche showcase at ADLM 2026 in Anaheim?

Roche will showcase integrated diagnostic systems and intelligent laboratory solutions at ADLM 2026, booth no. 2901, in Anaheim, California. Highlights include the AXELIOS 1 next-generation sequencing platform, the cobas® Mass Spec solution, cobas® pro and cobas® pure integrated solutions, cobas® 6800/8800 and 5800 systems, VENTANA® DP 600 slide scanner, BenchMark ULTRA PLUS system, and navify® Digital Solutions.

How does Roche’s cobas Mass Spec solution and AXELIOS 1 NGS platform support high-precision diagnostics and genomics research?

The cobas® Mass Spec solution, including the cobas® i 601 analyzer and Ionify® reagents with CLIA moderate complexity classification, automates end-to-end mass spectrometry workflows for routine core labs. The AXELIOS 1 NGS platform, powered by sequencing by expansion (SBX) technology, reduces sequencing time from days to hours, making genomics research faster, more flexible and more affordable for laboratories of all sizes.

Which Roche digital and point-of-care solutions at ADLM 2026 address workflow, workforce and decentralized testing needs?

Roche will feature navify® Digital Solutions (Lab Operations, Analytics, Quality Suite, POC Operations), upcoming navify Inventory Solutions and navify Algo Suite for EMR-integrated clinical algorithms. Point-of-care systems include the cobas® liat system, cobas® pulse system, cobas® Urisys® 1100, and CoaguChek® XS Plus system, all designed to support rapid triage, operational efficiency and data-driven clinical decisions across care settings.

Links

Roche

Tags

Mass SpectrometryMass spectrometry (MS) is a powerful analytical technique used to identify and quantify molecules based on the mass-to-charge ratio of gas-phase ions. It provides detailed information about the structure, composition, and properties of compounds and is widely used across fields such as environmental monitoring, materials science, drug discovery and development, food and beverage testing, and wider chemical research. Key MS techniques include tandem mass spectrometry (MS/MS), liquid chromatography–mass spectrometry (LS-MS) and inductively coupled plasma (ICP-MS). Choosing from these wide range of techniques and technologies can be a daunting task, so keep up to date with scientific applications, performance expectations, and customer reviews here all in one place. Visit our product directory to receive quotes direct from the manufacturer. Next Generation SequencingNext-generation sequencing (NGS), also known as whole-genome sequencing, high-throughput sequencing and massive parallel sequencing, produces and analyses thousands to millions of nucleotide sequences at once. Sequencing systems operate via varying technologies depending on the manufacturer, including sequencing by synthesis, ligation, pyrosequencing, ion semiconductor and single-molecule real-time sequencing. For NGS, library preparation is paramount to successful sequencing. In this section, explore a range of library preparation kits, from targeted, amplicon-based or hybridization-based kits including epigenomic, transcriptomic and genomic workflows to fragmentation kits. Find the best next-generation sequencing products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ADLMMolecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.ImmunohistochemistryImmunohistochemistry (IHC) is a technique used to detect specific proteins in tissue samples by using antibodies that bind to target antigens. IHC is widely applied in pathology, immunology, hematology and cancer diagnostics. Explore IHC tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.

Related articles